These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13640546)

  • 1. Study of the efficiency of gentian violet in the prevention of the transmission of Chagas'disease in blood banks: investigation of a volunteer, a receiver of dye-treated blood from an acute case.
    AMATO NETO V; MELLONE O
    Hospital (Rio J); 1959 Mar; 55(3):343-6. PubMed ID: 13640546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent data on the use of gentian violet in prevention of the transmission of Chagas'disease by blood transfusion].
    NUSSENZWEIG V; AMATO NETO V; MELLONE O
    Hospital (Rio J); 1959 Feb; 55(2):183-8. PubMed ID: 13640534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of triphenylmethane dyes on Trypanosoma cruzi in vitro; use of gentian violet in prevention of transmission of Chagas disease by blood transfusion].
    NUSSENZWEIG V; SONNTAG R; BIANCALANA A; DE FREITAS JL; AMATO NETO V; KLOETZEL J
    Hospital (Rio J); 1953 Dec; 44(6):731-44. PubMed ID: 13151630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Post-transfusion Chagas' disease].
    Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):135-7. PubMed ID: 3150608
    [No Abstract]   [Full Text] [Related]  

  • 5. The present state of chemoprophylaxis in transfusional Chagas' disease.
    de Souza HM
    Rev Soc Bras Med Trop; 1989; 22(1):1-3. PubMed ID: 2517799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Response to letter to the editor 23(1): 53, 1990: Risk of cancer development in recipients of gentian violet-treated blood. Validity of the interview].
    Luquetti AO
    Rev Soc Bras Med Trop; 1990; 23(4):237-8. PubMed ID: 2133593
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet.
    Docampo R; Moreno SN; Gadelha FR; de Souza W; Cruz FS
    Biomed Environ Sci; 1988 Dec; 1(4):406-13. PubMed ID: 3151757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study on the possibility of prevention of post-transfusional malaria, by using gentian violet].
    Neto VA; de Sant'Ana EJ; Silva Pinto PL; Moreira AA; Duarte MI; Campos R
    Rev Saude Publica; 1987 Dec; 21(6):497-500. PubMed ID: 3330860
    [No Abstract]   [Full Text] [Related]  

  • 9. [The danger of transmission of Chagas' disease by blood transfusion].
    ROSENBAUM MB; ALVAREZ AJ; CERISOLA JA
    Prensa Med Argent; 1957 Nov; 44(45):3305-8. PubMed ID: 13542485
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chagas' disease and blood transfusion: trypanocidal activity of maprotiline hydrochloride and gentian violet].
    Celentano AM; González Cappa SM
    Medicina (B Aires); 1988; 48(3):265-8. PubMed ID: 3150028
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and mode of action of gentian violet.
    Moreno SN
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():308-20. PubMed ID: 3150994
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolism and mode of action of gentian violet.
    Docampo R; Moreno SN
    Drug Metab Rev; 1990; 22(2-3):161-78. PubMed ID: 2272286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood tests for Chagas disease in prospective donors in blood banks in the states of São Paulo and Minas Gerais].
    BIANCALANA A; DE FREITAS JL; AMATO NETO V; NUSSENZWEIG V; SONNTAG R
    Hospital (Rio J); 1953 Dec; 44(6):745-9. PubMed ID: 13151631
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of physical and chemical agents of Trypanosoma cruzi in vitro].
    NUSSENZWEIG V; NUSSENZWEIG RS; DE FREITAS JL; AMATO NETO V; BIANCALANA A; KLOETZEL J
    Hospital (Rio J); 1954 May; 45(5):589-99. PubMed ID: 13183561
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate.
    Docampo R; Moreno SN; Cruz FS
    Mol Biochem Parasitol; 1988 Jan; 27(2-3):241-7. PubMed ID: 2830513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Blood Services to screen for Chagas disease.
    Comeau P
    CMAJ; 2007 Jul; 177(3):242. PubMed ID: 17664439
    [No Abstract]   [Full Text] [Related]  

  • 17. [CONFIRMATION OF A FURTHER CASE OF THE TRANSMISSION OF CHAGAS' DISEASE BY BLOOD TRANSFUSION].
    AMATONETO V; MAGALDI C; BIANCHI A
    Hospital (Rio J); 1963 Jul; 64():123-30. PubMed ID: 14054341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chagas' disease and blood transfusion].
    PELLEGRINO J
    Rev Bras Malariol Doencas Trop; 1959 Oct; 11():697-706. PubMed ID: 14484967
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted therapy of oral hairy leukoplakia with gentian violet.
    Bhandarkar SS; MacKelfresh J; Fried L; Arbiser JL
    J Am Acad Dermatol; 2008 Apr; 58(4):711-2. PubMed ID: 18342722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.